• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Resveratrol for protection against statin toxicity in C2C12 and H9c2 cells.白藜芦醇对 C2C12 和 H9c2 细胞中西他汀毒性的保护作用。
J Biochem Mol Toxicol. 2020 Jun;34(6):e22484. doi: 10.1002/jbt.22484. Epub 2020 Mar 20.
2
A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.一项针对 FDA 的 AERS 数据库的调查,该调查涉及与他汀类药物相关的肌肉和肌腱不良事件。
PLoS One. 2012;7(8):e42866. doi: 10.1371/journal.pone.0042866. Epub 2012 Aug 22.
3
Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway.溶血磷脂酸通过激活 LPA 受体 /PKC 通路抑制辛伐他汀诱导的肌毒性。
Molecules. 2020 Mar 27;25(7):1529. doi: 10.3390/molecules25071529.
4
Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats.他汀类药物在L6成纤维细胞和大鼠中引起骨骼肌毒性的潜在机制。
J Pharmacol Sci. 2009 Jan;109(1):94-101. doi: 10.1254/jphs.08238fp. Epub 2009 Jan 8.
5
Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.潜在非处方他汀类药物辛伐他汀、洛伐他汀、氟伐他汀和普伐他汀的药代动力学比较。
Clin Pharmacokinet. 2008;47(7):463-74. doi: 10.2165/00003088-200847070-00003.
6
Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system.他汀类药物相关神经认知障碍:基于 FDA 不良事件报告系统的真实世界药物警戒研究。
Expert Rev Clin Pharmacol. 2024 Mar;17(3):255-261. doi: 10.1080/17512433.2024.2311875. Epub 2024 Jan 31.
7
Proinsulin C-Peptide Enhances Cell Survival and Protects against Simvastatin-Induced Myotoxicity in L6 Rat Myoblasts.胰岛素原 C 肽可增强细胞活力并预防辛伐他汀诱导的 L6 大鼠成肌细胞肌毒性。
Int J Mol Sci. 2019 Apr 3;20(7):1654. doi: 10.3390/ijms20071654.
8
Mechanisms of simvastatin myotoxicity: The role of autophagy flux inhibition.辛伐他汀肌毒性的机制:自噬流抑制的作用。
Eur J Pharmacol. 2019 Nov 5;862:172616. doi: 10.1016/j.ejphar.2019.172616. Epub 2019 Aug 23.
9
Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity.单纯高脂血症以及高脂血症合并酸中毒均可增加他汀类药物所致肌毒性的发生率和严重程度。
Eur J Pharm Sci. 2017 Mar 30;100:163-175. doi: 10.1016/j.ejps.2017.01.018. Epub 2017 Jan 16.
10
Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2 , and CYP2C9 variants.他汀类药物不耐受的真实世界药物遗传学:SLCO1B1、ABCG2 和 CYP2C9 变异体的影响。
Pharmacogenet Genomics. 2023 Sep 1;33(7):153-160. doi: 10.1097/FPC.0000000000000504. Epub 2023 Jul 23.

引用本文的文献

1
Lovastatin and Resveratrol Synergistically Improve Wound Healing and Inhibit Bacterial Growth.洛伐他汀和白藜芦醇协同促进伤口愈合并抑制细菌生长。
Int J Mol Sci. 2025 Jan 20;26(2):851. doi: 10.3390/ijms26020851.
2
Simvastatin Inhibits NLRP3 Inflammasome Activation and Ameliorates Lung Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia via the KLF2-Mediated Mechanism.辛伐他汀通过 KLF2 介导的机制抑制 NLRP3 炎性小体激活并改善高氧诱导的支气管肺发育不良肺损伤。
Oxid Med Cell Longev. 2022 Apr 25;2022:8336070. doi: 10.1155/2022/8336070. eCollection 2022.
3
Pleiotropic use of Statins as non-lipid-lowering drugs.他汀类药物作为非降脂药物的多效性用途。
Int J Biol Sci. 2020 Aug 13;16(14):2704-2711. doi: 10.7150/ijbs.42965. eCollection 2020.

本文引用的文献

1
Letter by Zhou et al Regarding Article, "Statin Toxicity: Mechanistic Insights and Clinical Implications".周等人就“他汀类药物毒性:机制见解与临床意义”一文所写的信。
Circ Res. 2019 Jun 7;124(12):e120. doi: 10.1161/CIRCRESAHA.119.315210. Epub 2019 Jun 6.
2
Response by Ward et al to Letter Regarding Article, "Statin Toxicity: Mechanistic Insights and Clinical Implications".沃德等人对关于“他汀类药物毒性:机制见解与临床意义”一文的信件的回应。
Circ Res. 2019 Jun 7;124(12):e121-e122. doi: 10.1161/CIRCRESAHA.119.315233. Epub 2019 Jun 6.
3
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
4
Editorial commentary: The pleiotropic effect of statins on the atherosclerotic plaque and coronary heart disease.
Trends Cardiovasc Med. 2019 Nov;29(8):456-457. doi: 10.1016/j.tcm.2019.02.001. Epub 2019 Feb 10.
5
Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.他汀类药物作为一类药物和特定他汀类药物用于一级预防心血管疾病的疗效和安全性比较:一项纳入 94283 名参与者的随机试验的系统评价、荟萃分析和网络荟萃分析。
Am Heart J. 2019 Apr;210:18-28. doi: 10.1016/j.ahj.2018.12.007. Epub 2019 Jan 10.
6
Effect of statins on atherosclerotic plaque.他汀类药物对动脉粥样硬化斑块的影响。
Trends Cardiovasc Med. 2019 Nov;29(8):451-455. doi: 10.1016/j.tcm.2019.01.001. Epub 2019 Jan 7.
7
Geranylgeraniol Prevents Statin-Dependent Myotoxicity in C2C12 Muscle Cells through RAP1 GTPase Prenylation and Cytoprotective Autophagy.香叶基香叶醇通过 RAP1 GTP 酶异戊烯基化和细胞保护自噬防止 C2C12 肌肉细胞中他汀类药物依赖性肌毒性。
Oxid Med Cell Longev. 2018 May 21;2018:6463807. doi: 10.1155/2018/6463807. eCollection 2018.
8
Resveratrol attenuates denervation-induced muscle atrophy due to the blockade of atrogin-1 and p62 accumulation.白藜芦醇通过抑制肌肉萎缩蛋白和 p62 的积累来减轻失神经诱导的肌肉萎缩。
Int J Med Sci. 2018 Apr 3;15(6):628-637. doi: 10.7150/ijms.22723. eCollection 2018.
9
Resveratrol Improves Muscle Atrophy by Modulating Mitochondrial Quality Control in STZ-Induced Diabetic Mice.白藜芦醇通过调节 STZ 诱导的糖尿病小鼠的线粒体质量控制改善肌肉萎缩。
Mol Nutr Food Res. 2018 May;62(9):e1700941. doi: 10.1002/mnfr.201700941. Epub 2018 Apr 23.
10
Pre-loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI.对接受经皮冠状动脉介入治疗(PCI)的心绞痛和急性冠状动脉综合征患者进行他汀类药物预负荷治疗。
J Interv Cardiol. 2017 Dec;30(6):507-513. doi: 10.1111/joic.12421. Epub 2017 Aug 7.

白藜芦醇对 C2C12 和 H9c2 细胞中西他汀毒性的保护作用。

Resveratrol for protection against statin toxicity in C2C12 and H9c2 cells.

机构信息

Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona.

Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, Arizona.

出版信息

J Biochem Mol Toxicol. 2020 Jun;34(6):e22484. doi: 10.1002/jbt.22484. Epub 2020 Mar 20.

DOI:10.1002/jbt.22484
PMID:32196851
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8827215/
Abstract

Statins are among the most commonly prescribed drugs for the treatment of high blood cholesterol. Myotoxicity of statins in certain individuals is often a severe side effect leading to withdrawal. Using C2C12 and H9c2 cells, both exhibiting characteristics of skeletal muscle cells, we addressed whether resveratrol (RSV) can prevent statin toxicity. Statins decreased cell viability in a dose and time-dependent manner. Among the five statins tested, atorvastatin, simvastatin, lovastatin, pravastatin, and fluvastatin, simvastatin is the most toxic one. Simvastatin at 10 µM caused about 65% loss of metabolic activity as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays in C2C12 cells or H9c2 cells. Inhibition of metabolic activity correlates with an increase in caspase activity. RSV was found to protect H9c2 cells from simvastatin-induced activation of caspase-3/7. However, such protection was not found in C2C12 cells. This cell type-dependent effect of RSV adds to the complexity in muscle cell toxicity of statins.

摘要

他汀类药物是治疗高胆固醇血症最常用的药物之一。他汀类药物在某些个体中的肌毒性常常是导致停药的严重副作用。我们使用同时具有骨骼肌细胞特征的 C2C12 和 H9c2 细胞,研究白藜芦醇(RSV)是否可以预防他汀类药物毒性。他汀类药物以剂量和时间依赖的方式降低细胞活力。在所测试的五种他汀类药物中,阿托伐他汀、辛伐他汀、洛伐他汀、普伐他汀和氟伐他汀,辛伐他汀的毒性最大。辛伐他汀在 10μM 时,通过 C2C12 细胞或 H9c2 细胞中的 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐测定法,导致约 65%的代谢活性丧失。代谢活性的抑制与半胱天冬酶活性的增加相关。发现 RSV 可保护 H9c2 细胞免受辛伐他汀诱导的 caspase-3/7 激活。然而,在 C2C12 细胞中未发现这种保护作用。RSV 的这种细胞类型依赖性作用增加了他汀类药物对肌肉细胞毒性的复杂性。